Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery

Mark M. Walsh; Rashid Khan; Hau C. Kwaan; Matthew D. Neal

doi:10.1016/j.jamcollsurg.2021.03.003

Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery

Mark M. Walsh, Rashid Khan, Hau C. Kwaan, Matthew D. Neal

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1003-1006
Number of pages	4
Journal	Journal of the American College of Surgeons
Volume	232
Issue number	6
DOIs	https://doi.org/10.1016/j.jamcollsurg.2021.03.003
State	Published - Jun 2021

ASJC Scopus subject areas

Surgery

Access to Document

10.1016/j.jamcollsurg.2021.03.003

Cite this

@article{a0410821e3454cc9809eac8b05da6e2e,

title = "Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery",

author = "Walsh, {Mark M.} and Rashid Khan and Kwaan, {Hau C.} and Neal, {Matthew D.}",

note = "Funding Information: Support: Dr Neal receives research support from NIH and the US Department of Defense . Funding Information: Disclosures outside the scope of this work: Dr Walsh receives lecture payments from Alexion Speakers Bureau. Dr Neal receives payment for board membership from Janssen Pharmaceuticals and CSL Behring, and receives research support from Janssen Pharmaceuticals, Haemonetics, Accriva, Diagnostics, Instrument Laboratories, and Noveome Therapeutics. Other authors have nothing to disclose.Support: Dr Neal receives research support from NIH and the US Department of Defense.",

year = "2021",

month = jun,

doi = "10.1016/j.jamcollsurg.2021.03.003",

language = "English (US)",

volume = "232",

pages = "1003--1006",

journal = "Journal of the American College of Surgeons",

issn = "1072-7515",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy

T2 - A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery

AU - Walsh, Mark M.

AU - Khan, Rashid

AU - Kwaan, Hau C.

AU - Neal, Matthew D.

N1 - Funding Information: Support: Dr Neal receives research support from NIH and the US Department of Defense . Funding Information: Disclosures outside the scope of this work: Dr Walsh receives lecture payments from Alexion Speakers Bureau. Dr Neal receives payment for board membership from Janssen Pharmaceuticals and CSL Behring, and receives research support from Janssen Pharmaceuticals, Haemonetics, Accriva, Diagnostics, Instrument Laboratories, and Noveome Therapeutics. Other authors have nothing to disclose.Support: Dr Neal receives research support from NIH and the US Department of Defense.

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85103960308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103960308&partnerID=8YFLogxK

U2 - 10.1016/j.jamcollsurg.2021.03.003

DO - 10.1016/j.jamcollsurg.2021.03.003

M3 - Comment/debate

C2 - 33839011

AN - SCOPUS:85103960308

VL - 232

SP - 1003

EP - 1006

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 6

ER -

Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this